Traws Pharma, Inc. (TRAW)

Traws Pharma Statistics

Total Valuation

Traws Pharma has a market cap or net worth of $19.10 million. The enterprise value is $15.96 million.

Market Cap	19.10M
Enterprise Value	15.96M

Important Dates

The last earnings date was Friday, May 15, 2026, before market open.

Earnings Date	May 15, 2026
Ex-Dividend Date	n/a

Share Statistics

Traws Pharma has 10.16 million shares outstanding. The number of shares has increased by 429.93% in one year.

Current Share Class	10.16M
Shares Outstanding	10.16M
Shares Change (YoY)	+429.93%
Shares Change (QoQ)	+6.11%
Owned by Insiders (%)	8.49%
Owned by Institutions (%)	11.83%
Float	5.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.99
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	5.84
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.43

Current Ratio	0.43
Quick Ratio	0.36
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -5,639.19% and return on invested capital (ROIC) is -3,559.14%.

Return on Equity (ROE)	-5,639.19%
Return on Assets (ROA)	-90.09%
Return on Invested Capital (ROIC)	-3,559.14%
Return on Capital Employed (ROCE)	388.32%
Weighted Average Cost of Capital (WACC)	12.33%
Revenue Per Employee	$390,429
Profits Per Employee	-$1.99M
Employee Count	7
Asset Turnover	0.20
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +51.61% in the last 52 weeks. The beta is 1.47, so Traws Pharma's price volatility has been higher than the market average.

Beta (5Y)	1.47
52-Week Price Change	+51.61%
50-Day Moving Average	1.68
200-Day Moving Average	1.89
Relative Strength Index (RSI)	57.75
Average Volume (20 Days)	6,252,854

Short Selling Information

The latest short interest is 560,036, so 5.51% of the outstanding shares have been sold short.

Short Interest	560,036
Short Previous Month	405,599
Short % of Shares Out	5.51%
Short % of Float	10.44%
Short Ratio (days to cover)	2.26

Income Statement

In the last 12 months, Traws Pharma had revenue of $2.73 million and -$13.91 million in losses. Loss per share was -$1.52.

Revenue	2.73M
Gross Profit	2.73M
Operating Income	-19.62M
Pretax Income	-19.43M
Net Income	-13.91M
EBITDA	-19.51M
EBIT	-19.62M
Loss Per Share	-$1.52

Balance Sheet

The company has $3.13 million in cash and n/a in debt, with a net cash position of $3.13 million or $0.31 per share.

Cash & Cash Equivalents	3.13M
Total Debt	n/a
Net Cash	3.13M
Net Cash Per Share	$0.31
Equity (Book Value)	-5.31M
Book Value Per Share	-0.52
Working Capital	-7.54M

Cash Flow

Operating Cash Flow	-15.32M
Capital Expenditures	n/a
Depreciation & Amortization	61,000
Net Borrowing	n/a
Free Cash Flow	-18.19M
FCF Per Share	-$1.79

Margins

Gross Margin	100.00%
Operating Margin	-717.82%
Pretax Margin	-710.83%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Traws Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-429.93%
Shareholder Yield	-429.93%
Earnings Yield	-72.84%
FCF Yield	-95.23%

Analyst Forecast

The average price target for Traws Pharma is $8.00, which is 325.53% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.00
Price Target Difference	325.53%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	84.21%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 23, 2024. It was a reverse split with a ratio of 1:25.

Last Split Date	Sep 23, 2024
Split Type	Reverse
Split Ratio	1:25

Scores

Altman Z-Score	n/a
Piotroski F-Score	1